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Abstract
In analyzing the sequence tags for mutant mouse embryonic stem (ES) cell lines in BayGenomics
(a mouse gene-trapping resource), we identified a novel gene, Agpat6, with sequence similarities
to previously characterized glycerolipid acyltransferases. Agpat6’s closest family member is
another novel gene that we have provisionally designated Agpat8. Both Agpat6 and Agpat8 are
conserved from plants, nematodes, and flies to mammals. AGPAT6, which is predicted to contain
multiple membrane-spanning helices, is found exclusively within the endoplasmic reticulum in
mammalian cells. To gain insights into the in vivo importance of Agpat6, we used the Agpat6 ES
cell line from BayGenomics to create Agpat6-deficient (Agpat6−/−) mice. Agpat6−/− mice lacked
full-length Agpat6 transcripts, as judged by northern blots. One of the most striking phenotypes of
Agpat6−/− mice was a defect in lactation. Pups nursed by Agpat6−/− mothers die perinatally.
Normally, Agpat6 is expressed at high levels in the mammary epithelium of breast tissue, but not
in the surrounding adipose tissue. Histological studies revealed that the aveoli and ducts of
Agpat6−/− lactating mammary glands were underdeveloped, and there was a dramatic decrease in
size and number of lipid droplets within mammary epithelial cells and ducts. Also, the milk from
Agpat6−/− mice was markedly depleted in diacylglycerols and triacylglycerols. Thus, we identified
a novel glycerolipid acyltransferase of the endoplasmic reticulum, AGPAT6, which is crucial for
the production of milk fat by the mammary gland.
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BayGenomics is a genomics program that uses gene-trapping vectors to produce mutant
lines of mouse embryonic stem (ES) cells (http://baygenomics.ucsf.edu/) (1). The gene
inactivated by the insertion of the gene-trapping vector can easily be identified with a unique
DNA sequence tag. Thus far, BayGenomics has inactivated more than 3,000 unique genes in
ES cells and has distributed more than 2,500 different cell lines to the research community,
for the purpose of creating knockout mice. Aside from producing mutant ES cell clones,
BayGenomics also produces a few knockout mice from the gene-trap ES cell lines, with the
goal of identifying genes relevant to lipid metabolism and cardiopulmonary disease.
While analyzing the sequence tags for BayGenomics ES cell clones, we encountered a novel
gene with sequence similarities to 1-acylglycerol-3-phosphate O-acyltransferases [AGPATs,
which convert lysophosphatidic acid to phosphatidic acid (2, 3)] and other members of the
glycerolipid acyltransferase family. Because of amino acid sequence similarities to
AGPAT1, AGPAT2, and other putative AGPATs (AGPAT3, AGPAT4, and AGPAT5), the
novel gene was provisionally designated Agpat6. Although this provisional name was based
on similarities to other AGPATs, it should be noted that AGPAT6 also has sequence
similarities to a variety of “non-AGPAT” glycerolipid acyltransferases. At about the same
time, another report drew attention to the existence of Agpat6 in the human cDNA databases
(4); however, there have been no published data on the intracellular localization of the
enzyme or its in vivo importance.
The glycerolipid acyltransferase protein family, which has been defined largely on the basis
of amino acid sequence similarities, includes glycerol-3-phosphate acyltransferase (GPAM),
glyceronephosphate O-acyltransferase (GNPAT), tafazzin, lysocardiolipin acyltransferase
(LYCAT), 2-acylglycerophosphoethanolamine acyltransferase, the AGPATs, and a number
of novel enzymes of unknown function. Amino acid sequence alignments of GPAM,
AGPAT1, AGPAT2, and GNPAT have defined four regions of homology (motifs I–IV) that
represent signatures for glycerolipid acyltransferases (5–7). Site-directed mutagenesis,
followed by expression studies in Escherichia coli, have indicated that motifs I and IV are
involved in catalysis, whereas motifs II and III are required for glycerol-3-phophate binding
(5, 8, 9). Recent studies of naturally occurring mutations in AGPAT2 (10, 11) have
uncovered a fifth important sequence motif (V), but its function has not yet been identified.
The biochemical properties, subcellular localization, and biological relevance of GPAM,
GNPAT, tafazzin, LYCAT, AGPAT1, and AGPAT2, have been at least partially
characterized either in humans or mice (2, 3, 12–15). GPAM is located in mitochondria and
catalyzes the acylation of glycerol-3-phosphate at the sn-1 position to generate
lysophosphatidic acid, and studies with Gpam-deficient mice have revealed that this enzyme
plays a major role in triacylglycerol synthesis (12). GNPAT is located in peroxisomes and
catalyses the acylation of glycerone phosphate to generate 1-acyl-glycerone-3-phosphate, a
precursor in plasmalogen synthesis (16). Mutations in GNPAT cause rhizomelic
chondrodysplasia punctata (RCDP) type 2, characterized by shortening of the upper
extremities, mental retardation, and cataracts (13). The activity of tafazzin, which is located
in mitochondria, is not known with certainty, but it could be involved in transferring acyl
groups from phosphatidylcholine or phosphatidylethanolamine to monolysocardiolipin (17).
Mutations in tafazzin cause Barth syndrome, an X-linked disease associated with dilated
cardiomyopathy, skeletal myopathy, neutropenia, and growth retardation (14). Another
cardiolipin biosynthetic enzyme, acyl-CoA:monolysocardiolipin acyltransferase (LYCAT),
has been recently identified (15).
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Biochemical roles for AGPAT1 and AGPAT2 in generating phosphatidic acid have been
well documented (2, 3). Mutations in AGPAT2, which is expressed largely in adipose tissue,
cause congenital generalized lipodystrophy (10), a disease characterized by a striking
absence of subcutaneous and abdominal fat, hypertriglyceridemia, and severe insulin
resistance. The other putative AGPATs (AGPAT3, AGPAT4, AGPAT5, and AGPAT7) (18,
19) were identified by sequence homology, and little is known about their biochemical
properties or physiologic importance. AGPAT activity was attributed to AGPAT3,
AGPAT4, and AGPAT5 in one study (18), but the activity levels were very low and in no
way comparable to that observed for AGPAT2 (18). The physiological relevance of the
novel BayGenomics gene, Agpat6, had never been previously investigated.
We sought to determine the intracellular localization of AGPAT6 and to define its
relatedness, in terms of amino acid sequence, to known glycerolipid acyltransferases. In
addition, we sought to ascertain the biological importance of AGPAT6 by examining the
phenotypes of Agpat6-deficient mice. Here, we report that AGPAT6 is located exclusively
in the endoplasmic reticulum (ER) and that its absence leads to underdeveloped mammary
epithelium and the production of milk depleted in diacylglycerols and triacylglycerols. In
addition, we report the identification of another novel gene, provisionally designated
Agpat8, which is the closest homolog of Agpat6 within the glycerolipid acyltransferase




A mouse ES cell line (DTM030, strain 129/OlaHsd) containing an insertional mutation in
Agpat6 was identified by BayGenomics, a gene-trapping resource (1). The gene-trap vector
used (pGT1dTMpfs) contains a splice-acceptor sequence upstream of the reporter gene βgeo
(a fusion of β-galactosidase and neomycin phosphotransferase II) (1). As judged by 5′ rapid
amplification of cDNA ends (20), the insertional mutation in DTM030 was located in the
second intron of Agpat6. Thus, the mutation results in the production of an in-frame fusion
transcript consisting of exons 1 and 2 from Agpat6 and βgeo. Another BayGenomics ES cell
line, RRF360, was used to create Agpat4 knockout mice.
We determined the exact site of insertion of the vector within intron 2, which allowed us to
design a PCR strategy to genotype the mice. The following primers were used for
genotyping: primer 1, 5′-ACAGGCTTTTGTGGTTTGGTTTGCT-3′; primer 2, 5′-
AGAAATCCTCCCCAACAGTGGGACT-3′; primer 3 (from vector sequences), 3′-
CGTGTCCTACAACACACACTCCAACC-5′. The wild-type allele was detected with
primers 1 and 2 (located in sequences flanking the insertion, yielding a 458-bp product),
while the mutant allele was detected with primers 1 and 3, yielding a 378-bp fragment.
ES cell line DTM030 was injected into C57BL/6 blastocysts to generate chimeric mice,
which were bred to establish Agpat6 knockout mice. All mice had a mixed genetic
background (C57BL/6 and 129/OlaHsd). The mice were weaned at 21 days of age, housed
in a barrier facility with a 12-h light/12-h dark cycle, and fed a chow diet containing 4.5%
fat (Ralston Purina, St. Louis, MO).
Northern blots
Total RNA was isolated from 50–150 mg of mouse tissue with Tri-Reagent (Sigma, St.
Louis, MO). Total RNA (5 μg) was separated by electrophoresis on 1% agarose/
formaldehyde gels and transferred to a Nytran SuPerCharge membrane (Schleicher &
Schuell, Keene, NH). A mouse multiple-tissue poly(A)+ RNA blot and a mouse embryo
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poly(A)+ RNA blot (Clontech, Palo Alto, CA) were used to determine the tissue pattern of
Agpat6 expression in adult mice and to examine the temporal expression of Agpat6 during
embryogenesis. Bands on northern blots were visualized by autoradiography (Fuji Super RX
films, Fujifilm, Tokyo, Japan) and quantified by densitometry (Molecular Imager FX, Bio-
Rad, Hercules, CA). A 3′ UTR Agpat6 cDNA probe (a region not conserved in Agpat8) was
amplified by RT-PCR with 5′-GTGGCAGGACAAGGTCAGAGCTACA-3′ and 5′-
TCCCTCCTGACTCACCAGTTCTTCC-3′. The lacZ probe was prepared as described
before (21). β-Actin and 18S cDNA probes were used as controls for RNA integrity and
loading. [32P]dCTP-labeled cDNA probes were prepared with All-in-One random prime
labeling mixture (Sigma). Standard prehybridization, hybridization, and washing procedures
were used (21).
Western blots
The complete open reading frame of Agpat6 was amplified from a mouse embryo cDNA
library by RT-PCR with primers 5′-ACCATGTTCCTGTTGCTACCT-3′ and 5′-
GGACCGGCTGCGGTCCTCATGGTTTCC-3′. For expression in mammalian cells, the
Appat6 coding sequence was cloned in-frame with a carboxyl-terminal V5-His tag into
pcDNA3.1/V5-His TOPO TA expression vector (Invitrogen, Carlsbad, CA). For expression
in insect cells, Agpat6 was amplified by PCR from pcDNA3.1/V5-His TOPO with the
carboxyl-terminal V5-His tag with primers 5′-
ATCGGAATTCATGTTCCTGTTGCTACCT-3′ and 5′-
CGATGAATTCTCAATGGTGATGGTGATGATGACC-3′, subcloned into pCR2.1
(Invitrogen), and then subsequently cloned into the EcoRI site into pBacPAK8 (Clontech).
The integrity of the Agpat6 sequence within each construct was verified by sequencing.
High-Five insect cells infected with carboxyl-teminal-V5-tagged Agpat6, Agpat2, or Gpam-
recombinant baculovirus, or COS-7 cells transfected with the Agpat6-pcDNA3.1/V5-His
construct were collected in RIPA buffer containing a mixture of protease inhibitors
(Complete Mini EDTA-free, Roche Applied Science, Indianapolis, IN). Samples were
sonicated on ice and clarified by centrifugation at 500 × g for 10 min at 4°C. The protein
content of the supernatant fluid (whole-cell extract) was determined with a Bradford assay
(Bio-Rad). Denatured proteins (5 ng for insect cell extracts; 1 μg for COS-7 cell extracts)
were size-fractionated on 4–12% Bis-Tris NuPAGE gels (Invitrogen). After electrotransfer
to a sheet of nitrocellulose membrane (Invitrogen), the blots were blocked with phosphate-
buffered saline containing 0.2% Tween and 5% nonfat powdered milk overnight at 4°C, and
then incubated for 1 h at room temperature with a horseradish peroxidase–conjugated mouse
monoclonal antibody against the V5 tag (Invitrogen) (1:5,000). Antibody binding was
detected with the ECL Plus Western blotting kit (Amersham Biosciences, Piscataway, NJ)
and Fuji Super RX x-ray film (Fujifilm).
Histology and immunohistochemistry
Mice were anesthetized intraperitoneally with a ketamine/xylazine cocktail and perfusion-
fixed with normal saline followed by 4% paraformaldehyde. For β-galactosidase staining,
tissues were fixed and stained as previously described (21). For hematoxylin/eosin staining,
mammary glands were fixed in 10% buffered formalin for 24 h, dehydrated in ethanol,
transitioned into xylene, embedded in paraffin, sectioned (1 μm-thick), and stained.
For fat staining, mice were deeply anesthetized intraperitoneally with a ketamine/xylazine
cocktail, and perfusion-fixed with 0.1 M cacodylate followed by 2.5% glutaraldehyde in 0.1
M cacodylate. Mammary glands were dissected out and cleaved into thin slices to ensure
thorough fixation. After fixation, tissues were stained in 1% osmium tetroxide, dehydrated
in ethanol, transitioned into acetonitrile, and then embedded in Epon resin.
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For some immunohistochemistry studies, the Agpat6-pcDNA3.1/V5-His construct described
above was transfected into HeLa cells. AGPAT6 subcellular localization was compared to
that of protein disulfide isomerase (PDI, an ER marker), and of manganese superoxide
dismutase (MnSOD, a mitochondrial marker). The following antibodies were used: affinity
purified rabbit anti-6xHistine (1:6,000; Immunology Consultants Laboratory, Newberg,
OR); Alexa Fluor 568-labeled goat anti-rabbit IgG (1:800, Molecular Probes, Eugene, OR);
mouse monoclonal anti-PDI (1:700, Abcam, Cambridge, MA); Alexa Fluor 488-labeled goat
anti-mouse IgG (1:800, Molecular Probes); FITC-conjugated mouse anti-V5 tag (1:1,500,
Invitrogen); rabbit polyclonal anti-MnSOD (1 μg/ml, Stressgen, Victoria, BC, Canada);
Cy3-labeled goat anti-rabbit IgG (1:800, Abcam).
In addition, the complete coding sequences for Agpat2, Agpat6, and Gpam were inserted in-
frame with a carboxyl-terminal enhanced green fluorescent protein marker in pECFP-N1
(Clontech). The ECFP-tagged constructs were expressed in COS-1 cells along with M1-
YFP, a YFP-tagged ER marker (22). To assess mitochondrial localization, ECFP-tagged
constructs were expressed in COS-1 cells labeled with a MitoTracker dye (Molecular
Probes). Cells were imaged alive with an inverted Zeiss 510 laser scanning confocal
microscope (63× lens).
Analysis of lipids in milk
Three hours after removing newborn pups, lactating females were given two successive
intraperitoneal injections of oxytocin (5 μl/g of body weight of a 20 U/ml solution,
injections separated by 20 min). At the time of the second oxytocin injection, mice were
deeply anesthetized with a ketamine/xylazine cocktail, and milk was collected from the
mammary glands and stored at −80°C for analysis. For all experiments, the milk was
collected 24 h postpartum, when pups were still alive and suckling.
Milk lipids were extracted in the presence of authentic internal standards by the method of
Folch et al. (23) with chloroform:methanol (2:1, v/v). Twenty microliters of milk were used
for each analysis. In some experiments, neutral lipids were separated by thin layer
chromatography in hexane:ethyl ether:acetic acid (80:20:2), subsequently visualized with
iodine vapor, and lipids were identified by comigration with lipid standards. In other
experiments, individual lipid classes within each extract were separated by preparative
HPLC. Each isolated lipid class fraction was trans-esterified in 3N methanolic-HCl in a
sealed vial under nitrogen at 100°C for 45 min. The fatty acid methyl esters were extracted
from the mixture with hexane containing 0.05% butylated hydroxytoluene and prepared for
gas chromatography by sealing the hexane extracts under nitrogen. Fatty acid methyl esters
were then separated and quantified by capillary gas chromatography with a gas
chromatograph (Hewlett-Packard model 6890, Wilmington, DE) equipped with a 30-m
DB-225MS capillary column (J&W Scientific, Folsom, CA) and a flame-ionization detector,
as described previously (24). Lipid metabolome data were expressed as nanomoles (nM) per
gram and were assembled in tables as mean ± standard deviation for each group.
RESULTS
Agpat6 knockout mice
The BayGenomics library of mutant ES cells contained a mouse ES cell line with an
insertional mutation in Agpat6, which was used to generate Agpat6-deficient mice. The site
of insertion was identified within intron 2, making it possible to design a PCR strategy for
distinguishing heterozygous (Agpat6+/−) from homozygous (Agpat6−/−) mice (Fig. 1A). As
expected, full-length Agpat6 transcripts were absent in Agpat6−/− embryos (Fig. 1B).
Beigneux et al. Page 5














AGPAT6 is predicted to contain at least two transmembrane helices (Fig. 2A), as well as a
peptide signal and a peptide cleavage site after residue 38
(http://www.cbs.dtu.dk/services/SignalP/). When expressed into COS-7 or insect cells, the
C-terminal V5-tagged version of AGPAT6 migrates at 48 kDa, lower than the predicted size
(52.2 kDa) for the full open reading frame (Fig. 2B, C). However, the predicted size of
AGPAT6 after cleavage of the 38 amino acids signal peptide is 48 kDa, the size that we
observed by western blotting. In contrast, the molecular weight of AGPAT2 by western
blotting, 31 kDa, was the same as the predicted size of its entire open reading frame.
AGPAT6 is located in the ER
To assess the subcellular localization of AGPAT6, we constructed a green fluorescent
protein–tagged AGPAT6 and transfected it into COS-1 cells. These studies revealed that
AGPAT6 is located in the ER, and none was in the mitochondria (Fig. 3A). As expected,
GPAM was located entirely in the mitochondria, and AGPAT2 was located entirely in the
ER (Fig. 3A). Immunofluorescence studies with a V5-His-tagged AGPAT6 in HeLa cells
also indicated that AGPAT6 is an ER protein (Fig. 3B).
AGPAT6 expression patterns in mice
β-Galactosidase staining of tissues from Agpat6−/− embryos revealed that Agpat6 is
expressed in the brain, dorsal fat pad, lung, liver, and a wide variety of mesenchymal tissues,
including the mesenchyme of the gut and lung (Fig. 4A). Northern blots revealed that
Agpat6 is expressed at high levels throughout embryogenesis (Fig. 4B).
In adult wild-type mice, Agpat6 is expressed in a wide variety of tissues, including kidney,
liver, brain, the ovarian fat pad, and testes, as judged by northern blots (Figs. 5A, B). Agpat6
is expressed at particularly high levels in brown adipose tissue (Fig. 5B). β-Galactosidase
staining confirmed high-level of Agpat6 expression in brown adipose tissue (Fig. 5C) and
showed that, in the testis, Agpat6 is expressed primarily in spermatids, with lower levels of
expression in Sertoli cells (Fig. 5D). In the adult brain, Agpat6 is expressed predominantly
in cerebellum (Fig. 5E) and hippocampus (Fig. 5F). In the kidney, Agpat6 is expressed in
tubular cells (Fig. 5G).
A role for AGPAT6 in milk production
Agpat6−/− mice were born at the expected mendelian frequency from crosses between
heterozygous mice, indicating that, despite prominent expression in embryos, Agpat6 is not
required for survival. However, offspring derived from Agpat6−/− females die within 48 h
unless they are transferred to a foster mother. Very rarely, pups that are nursed by Agpat6−/−
females survive the early postnatal period, but those mice are invariably runts and die by 3–
4 weeks of age. These observations led us to suspect that Agpat6 could have a role in
lactation.
Agpat6 is expressed in nonlactating mammary gland, and the expression levels are
upregulated during lactation, as judged by northern blot analysis. This upregulation was
evident both for the full-length Agpat6 transcript in wild-type mice, as well as for the
Agpat6–βgeo fusion transcript in Agpat6−/− mice (Fig. 6A). β-Galactosidase staining
revealed that Agpat6 is expressed predominantly in epithelial cells of the mammary gland;
no staining could be detected in the surrounding white adipose tissue (Fig. 6B). Hematoxylin
and eosin–stained sections revealed that the alveoli and ducts of the mammary glands of
Agpat6−/− lactating females were underdeveloped compared with those of wild-type mice
(Fig. 6C). Furthermore, reduced numbers of fat droplets were evident in the epithelial cells
of Agpat6−/− mammary glands when compared to wild-type controls (Fig. 6D).
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Agpat6−/− mothers had some capacity to make milk—evident by a milk stripe in newborn
mouse pups (Fig. 7A). However, the amount of fat in the milk was reduced. Osmium
tetroxide–stained sections of mammary gland revealed a decrease in the size and the amount
of lipid droplets in the alveoli and ducts of Agpat6−/− mammary glands (Fig. 7B), compared
with the alveoli of wild-type females (Fig. 7C). In addition, thin layer chromatography
revealed that the milk from homozygous lactating females was depleted in triacylglycerols
(Fig. 7D). Gas chromatography–based measurements revealed an ~90% reduction in
diacylglycerols and triacylglycerols in the milk of Agpat6−/− mice (Fig. 7E).
The fact that minimal amount of milk fat were evident in the mammary epithelium of
Agpat6-deficient mice suggests the possibility that another glycerolipid acyltransferase
might have a redundant role in producing triglycerides in mammary epithelium. Ultimately,
understanding lipid synthesis in mammary epithelium will probably require the development
of reporter alleles for all of the different glylcerolipid acyltransferase enzymes. Thus far, we
have developed a reporter allele for Agpat4 (BayGenomics cell line RRF360); that gene is
clearly not expressed in mammary epithelium or in the surrounding adipose tissue (Fig. 8A),
while it is expressed strongly in the Sertoli cells of the testis (Fig. 8B).
DISCUSSION
In this study, we report the discovery, within the BayGenomics gene-trapping resource, of
Agpat6, a new member of the glycerolipid acyltransferase family. AGPAT6 is 48 kDa in
size (with the V5-His tag) and is found exclusively within the ER. Agpat6 is predominantly
expressed in brown adipose tissue and mammary epithelium. The milk from Agpat6−/− mice
is depleted in diacylglycerols and triacylglycerols, and the mammary epithelium from
Agpat6−/− mice is underdeveloped and depleted in intracellular fat droplets. In an
accompanying article (25), we show that the triacylglycerol content of brown and white
adipose tissue in Agpat6−/− mice is also significantly reduced. These experimental findings,
together with sequence similarities between AGPAT6 and other glycerolipid
acyltransferases (Table 1), suggest that AGPAT6 is a bona fide acyltransferase with an
important role in the synthesis of triacylglycerols.
The mammary gland abnormalities in Agpat6−/− mice are reminiscent of those in mice
lacking acylCoA:diacylglycerol acyltransferase 1 (DGAT1), an enzyme that adds an acyl
group to diacylglycerol to generate triacylglycerols. Dgat1−/− nursing mothers have
underdeveloped mammary glands and lack the ability to produce triacylglycerol-rich milk
droplets (26). The fact that the mammary glands from Agpat6 and Dgat1 knockout females
appeared underdeveloped suggests that defective lipid biosynthetic pathways interfere,
directly or indirectly, with mammary gland development.
This identification of Agpat6 within BayGenomics illustrates the utility of gene trapping for
inactivating a broad spectrum of genes, including novel genes that had escaped scientific
scrutiny. Once the sequence tag for the Agpat6 ES cell line was in hand, we were able to
classify Agpat6 as being a member of the glycerolipid acyltransferase family, and then move
on to examine the mouse and human genomes for additional Agpat6-like sequences. By
searching the DNA sequence databases, we quickly identified a novel, never-previously-
reported gene resembling Agpat6, which we have provisionally designated Agpat8 (Table 1).
Both AGPAT6 and AGPAT8 contain the classic sequence motifs (I–IV) characteristic of
glycerolipid acyltransferases (5–7). When the sequences spanning motifs I–IV were
analyzed for relatedness, it was apparent that AGPAT6 and AGPAT8 were most related to
each other (Fig. 9) (66% identical at the amino acid level, but only ~2–15% identical with
the other family members). More importantly, we found that both AGPAT6 and AGPAT8
contain sequences within motifs I–IV that distinguish them from other members of the
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family (Table 1). Domain III is strikingly conserved between AGPAT6 and AGPAT8,
representing a signature sequence for these two proteins (Table 1). Also, the arginine in the
VPEGTR consensus sequence within motif III is changed to a cysteine in AGPAT6 and
AGPAT8, a feature shared only by AGPAT7 and the unknown protein at locus 270084.
Remarkably, orthologues for Agpat6 and Agpat8 appear to exist in the genomes of plants,
worms, and flies (Table 1), suggesting that, together, AGPAT6 and AGPAT8 probably play
a unique, fundamental, and conserved function in lipid biosynthesis.
By analyzing conserved sequences (motifs I–IV) from multiple glycerolipid acyltransferases
in four species (human, mouse, D. melanogaster, and C. elegans), we divided the family
into eight subgroups (separated by double horizontal lines in Table 1). AGPAT1 and
AGPAT2, which have been proven to carry out the AGPAT reaction (conversion of
lysophosphatidic acid to phosphatidic acid) (2, 3), belong to the same subgroup. AGPAT3,
AGPAT4, and AGPAT5, which have been reported to have very weak AGPAT activities
(18), constitute two distinct subgroups. GPAM and GNPAT, two enzymes that add acyl
groups to the sn-1 position (16, 27–29), are more closely related to each other than to any
other member of the family. Lysocardiolipin acyltransferase (LYCAT) (15) falls into a fifth
subgroup. Interestingly, we identified three putative C. elegans orthologues for mammalian
LYCAT (15). Tafazzin falls into a sixth subgroup; tafazzin is involved in cardiolipin
remodeling but its precise biochemical role remains to be established (17). AGPAT7 (19)
and a closely related novel protein (locus 270084) form a seventh subgroup; their biological
importance and biochemical function remain to be determined. AGPAT6 and AGPAT8
form the eighth subgroup.
For the entire glycerolipid acyltransferase family, we hypothesize that sequence relatedness
within domains I–IV will ultimately be shown to correlate with biochemical function. For
example, in the case of AGPAT6 and AGPAT8, we hypothesize that these two enzymes will
ultimately be shown to have acyl acceptor and/or donor preferences that are similar to each
other and distinct from those of other AGPATs, GPAMs, GNPATs, or LYCATs.
The identification of enzymatic activities for putative lipid biosynthetic enzymes can be
straightforward (2, 3, 30, 31), but in some cases has been very challenging. For example,
despite sequence motifs suggesting an acyltransferase activity (32) and despite years of
biochemical studies by multiple groups, the biochemical role for tafazzin in cardiolipin
remodeling has not yet been identified with certainty. This has certainly been the case for
several of the AGPATs.
We expressed AGPAT2, GPAM, and AGPAT6 in insect cells, with sequence-verified
plasmids, and then tested the membrane fractions for GPAM or AGPAT activities under a
variety of reaction conditions. While the biochemical activities of our experimental controls,
GPAM and AGPAT2, were invariably extremely robust (>5–10×background), we have not
observed any AGPAT or GPAM activities in insect cell membranes overexpressing
AGPAT6 (at least no activity above background) (A. Beigneux, S. G. Young, unpublished
results). Similarly, we have not identified AGPAT or GPAM activities in E. coli membranes
overexpressing AGPAT6.
One way to explain these results, of course, is to postulate that none of the reaction
conditions were appropriate for AGPAT6, although they were perfectly suitable for the
AGPAT2 and GPAM controls. This is definitely possible. For example, DGAT1 and
DGAT2 carry out the same reaction but have different requirements for magnesium (31), so
it would be a mistake to assume that AGPAT2 and AGPAT6 would share identical in vitro
reaction conditions. Given the phenotypes of the mice, an AGPAT or GPAM activity for
AGPAT6 would make a lot of sense. A reduced capacity for synthesizing lysophosphatidic
Beigneux et al. Page 8













acid or phosphatidic acid would probably explain reduced amounts of diacylglycerols and
triacylglycerols in the milk and in the brown fat (25) of Agpat6−/− mice.
On the other hand, it is possible that AGPAT6 catalyzes a distinct biochemical activity. One
reason for suspecting a different activity is that we have been unable, thus far, to detect even
a small increase in AGPAT or GPAM activity in AGPAT6-enriched membranes, under a
variety of assay conditions with various sn-1-acylglycerols, and acyl-CoA species as
substrates. A second reason for suspecting a different enzymatic function is that it would be
astonishing if mammals (and lower organisms such as worms and flies) truly require seven
or more distinct AGPAT enzymes. Enzymes for crucial steps in lipid biosynthesis are
frequently redundant (6), but the need for seven or more different AGPATs would be quite
remarkable, particularly since the fatty acyl chain specificities of AGPAT1 and AGPAT2
are broad (2, 3) and since the loss of AGPAT2 causes such striking disease phenotypes (33).
In the end, biochemical studies, as well as the characterization of knockout mouse for each
of the glycerolipid acyltransferases, will be critical for understanding lipid synthesis and
lipid storage in different tissues, and for understanding the potential relevance of this family
of enzymes to health and disease.
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An insertional mutation in Agpat6. (A) Schematic of the insertion event, and the detection of
the insertional mutation by PCR with genomic DNA from Agpat6+/+, Agpat6+/−, and
Agpat6−/− mice. Numbers indicate exons. Primer orientation and location are indicated with
arrows. SA, splice acceptor; SV40pA, poly(A) tail. (B) Northern blot with total RNA
showing the expression of Agpat6 in Agpat6+/+, Agpat6+/−, and Agpat6−/−embryos. An 18S
cDNA was used for normalization.
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Structural features of AGPAT6. (A) Kyte-Doolittle hydrophobicity profiles for mouse
AGPAT6, AGPAT1, and AGPAT2. Numbers on the X axis refer to amino acid residues.
AGPAT6 (456 amino acids) is larger than AGPAT1 (285 amino acids) and AGPAT2 (278
amino acids), mainly because AGPAT6 contains 140 extra amino acid residues upstream to
the region containing the signature glycerolipid acyltransferase sequence motifs (5–9)
(highlighted in grey). Bold horizontal lines indicate predicted transmembrane domains (as
judged by http://www.cbs.dtu.dk/services/TMHMM-2.0/,
http://sosui.proteome.bio.tuat.ac.jp/sosuiframe0E.html, and
http://smart.embl-heidelberg.de/). The question mark in the AGPAT6 sequence indicates a
potential transmembrane domain that is predicted by one of the three sequence-analysis
programs (http://sosui.proteome.bio.tuat.ac.jp/sosuiframe0E.html). (B) Western blot, with an
anti-V5 antibody, showing that the molecular weight of the tagged version of AGPAT6 is 48
kDa, both in extracts from COS-7 cells transfected with V5-tagged Agpat6 (+) and in High-
Five cells infected with a V5-tagged Agpat6 recombinant baculovirus (+). The 48-kDa band
was absent in extracts from nontransfected COS-7 cells (−) and noninfected High-Five cells
(−). (C) Western blot of total membrane fractions (5 ng each) from High-Five cells infected
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with V5-tagged AGPAT6 (48 kDa), AGPAT2 (31 kDa), or GPAM (93.7 kDa)
baculoviruses. The molecular weight of AGPAT2 was identical to that predicted for the full-
length open reading frame. Membranes from noninfected cells (niC) were included as a
control.
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AGPAT6 localizes to the ER. (A) ECFP-tagged Agpat2, Agpat6, or Gpam constructs were
cotransfected into COS-1 cells with M1-YFP (a YFP-tagged ER marker (22)). To assess
mitochondrial localization, ECFP-tagged constructs were expressed in COS-1 cells labeled
with a MitoTracker dye. ECFP–AGPAT6 colocalized with M1-YFP, but not with the
MitoTracker dye, indicating an ER membrane localization for AGPAT6. A representative
enlargement is shown as an insert in the panels for AGPAT6. AGPAT2 and GPAM were
used as controls for ER and mitochondrial localization, respectively. (B) HeLa cells
transfected with an expression vector for a V5-His-tagged Agpat6. The subcellular
localization of AGPAT6 was compared with that of an ER marker, protein disulfide
isomerase (PDI), and a mitochondrial marker, manganese superoxide dismutase (MnSOD).
Merged images show colocalization of AGPAT6 and PDI but not MnSOD.
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Agpat6 expression during development. (A) β-Galactosidase staining of an Agpat6 knockout
embryo (E15). Arrows point to expression in brain (b), dorsal fat pad (df), lung (lg), liver
(lv) and mesenchyme (m) of the guts. (B) A mouse embryo poly(A)+ RNA blot showing the
expression of Agpat6 throughout embryogenesis in wild-type mice. β-Actin was used for
normalization.
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Agpat6 expression in adult mice. (A) A mouse poly(A)+ RNA blot showing the expression
of Agpat6 in adult tissues. A β-Actin cDNA was used for normalization. (B) A mouse total
RNA blot showing prominent expression of Agpat6 in testis and brown adipose tissue in
adult mice. A 18S cDNA was used for normalization. BAT, brown adipose tissue. (C–G) β-
Galactosidase staining of brown adipose tissue (C), testis (D), cerebellum (E), hippocampus
(F), and kidney (G) from a 6-week-old Agpat6−/− male. Arrows point to expression in
spermatids (sp), Sertoli cells (s), cerebellar lobule (cb), hippocampus (h), dentate gyrus (dg),
and tubular cells (t).
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Expression of Agpat6 in mammary gland. (A) Northern blot analysis of total RNA from
Agpat6+/+ and Agpat6−/− mammary glands. An Agpat6 cDNA was used to detect the full-
length Agpat6 mRNA in wild-type tissues, and a lacZ probe was used to detect the fusion
transcript in the knockout mice. An 18S cDNA was used for normalization. (B) β-
Galactosidase staining of mammary gland from Agpat6−/− and Agpat6+/+ lactating females,
revealing a high level of Agpat6 expression in the epithelial cells of the mammary gland. (C,
D) Hematoxylin and eosin staining of Agpat6−/− and Agpat6+/+ mammary glands, showing
reduced size and number of alveoli in the mammary glands of lactating Agpat6−/− mice (C)
as well as reduced numbers of fat droplets in Agpat6-deficient epithelial cells (D). In all
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experiments, the mammary glands were dissected 24 h postpartum, when pups were still
alive and suckling.
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Influence of Agpat6 deficiency on the composition of milk. (A) Milk streak in a pup nursed
by an Agpat6−/− female. (B, C) Osmium tetroxide–stained sections of mammary glands
from Agpat6−/− (B) and Agpat6+/+ (C) lactating females, showing decreased lipid droplets in
the alveoli and ducts of the mammary glands from the Agpat6−/− female. (D) Reduced
triacylglycerol (TG) content of milk from an Agpat6−/− female, compared to heterozygous
and wild-type controls, as assessed by thin layer chromatography. The intensity of the
cholesterol ester (CE) band was not significantly reduced in milk from Agpat6−/− females.
(E) Reduced diacylglycerol (DAG) and triacylglycerol (TG) content of milk from Agpat6−/−
females, as assessed by gas chromatography. In all experiments, the milk was collected (or
the mammary glands were dissected) 24 h postpartum, when pups were still alive and
suckling.
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Agpat4 expression in mammary gland (A) and testis (B), as judged by β-galactosidase
staining. Agpat4 expression in the mammary gland was undetectable, whereas it was robust
in the Sertoli cells of the testis.
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Dendrogram illustrating the amino acid sequence relatedness of mouse glycerolipid
acyltransferases within the region of the proteins spanning functional domains I–IV (5–7).
Alignments were performed with the Clustal W algorithm (http://www.ebi.ac.uk/clustalw/).
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TABLE 1
Proposed glycerolipid acyltransferase subgroups as assessed by alignment of amino acid sequences of putative
orthologues from human, mouse, C. elegans, and D. melanogaster.
Numbers refer to amino acid residue position within each protein sequence. Bolded characters show consensus motifs that define the glycerolipid
acyltransferase family. Blue characters represent amino acid identity that helped discern eight different subgroups within the glycerolipid
acyltransferase family.
a
Acl-1 through 11 represent putative orthologues in C. elegans as per best possible match.
b
Gene name starting by CG represent putative orthologues in D. melanogaster as per best possible match.
c
Putative orthologue in Arabidopsis thaliana as per best possible match.
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